These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7826085)

  • 1. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
    Shimada Y; Yoshino M; Wakui A; Nakao I; Futatsuki K; Sakata Y; Kambe M; Taguchi T; Ogawa N
    J Clin Oncol; 1993 May; 11(5):909-13. PubMed ID: 8487053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
    Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of weekly low-dose CPT-11 combined with 5-FU/l-LV therapy for advanced and recurrent colorectal cancer--preliminary study].
    Tsubono M; Kaneko I; Kii E; Murata T; Deguchi Y; Sonoda K; Yasuda K
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1273-8. PubMed ID: 16969024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
    Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.
    Rougier P; Bugat R; Douillard JY; Culine S; Suc E; Brunet P; Becouarn Y; Ychou M; Marty M; Extra JM; Bonneterre J; Adenis A; Seitz JF; Ganem G; Namer M; Conroy T; Negrier S; Merrouche Y; Burki F; Mousseau M; Herait P; Mahjoubi M
    J Clin Oncol; 1997 Jan; 15(1):251-60. PubMed ID: 8996150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-dose CPT-11 against a recurrent rectal cancer--a case report].
    Takahashi Y; Omote K; Kitagata S; Mai M
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1193-6. PubMed ID: 10431589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second-line chemotherapy with bi-weekly CPT-11 and cisplatin for recurrent colorectal cancer resistant to 5-FU based chemotherapy].
    Suzuki S; Harada N; Takeo Y; Tanaka S; Hayashi T; Suzuki M; Hanyu F
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1007-10. PubMed ID: 16044963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
    Fukuoka M; Niitani H; Suzuki A; Motomiya M; Hasegawa K; Nishiwaki Y; Kuriyama T; Ariyoshi Y; Negoro S; Masuda N
    J Clin Oncol; 1992 Jan; 10(1):16-20. PubMed ID: 1309380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
    Conti JA; Kemeny NE; Saltz LB; Huang Y; Tong WP; Chou TC; Sun M; Pulliam S; Gonzalez C
    J Clin Oncol; 1996 Mar; 14(3):709-15. PubMed ID: 8622015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
    Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPT-11: the European clinical development.
    Terret C; Couteau C; Armand JP
    J Infus Chemother; 1996; 6(3):152-7. PubMed ID: 9229329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of liver metastasis and extrahepatic metastasis with hepatic arterial infusion of CDDP, CPT-11, and 5-FU].
    Doi K; Ohchi T; Ogata K; Kikuchi N; Ishimoto T; Hashimoto D; Ochiai T; Muranaka T; Ogawa M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1668-70. PubMed ID: 15553678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment with irinotecan and doxifluridine: optimal dosing schedule in murine models and in a phase I study for metastatic colorectal cancer.
    Mishima H; Kato T; Yanagisawa M; Tsujinaka T; Nishisho I; Tsujie M; Fujimoto-Ouchi K; Tanaka Y; Kikkawa N
    Chemotherapy; 2005 Mar; 51(1):32-9. PubMed ID: 15767743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase I study of weekly administration of CPT-11 in lung cancer].
    Fukuoka M; Negoro S; Niitani H; Furue H; Hasegawa K; Hara Y; Hara N; Taguchi T
    Gan To Kagaku Ryoho; 1990 May; 17(5):993-7. PubMed ID: 2159268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four cases of recurrent breast cancer effectively treated by the new antitumor agent, CPT-11 (irinotecan)].
    Doihara H; Takashima S; Yokoyama N
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1263-6. PubMed ID: 8031169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].
    Negoro S; Fukuoka M; Niitani H; Suzuki A; Nakabayashi T; Kimura M; Motomiya M; Kurita Y; Hasegawa K; Kuriyama T
    Gan To Kagaku Ryoho; 1991 May; 18(6):1013-9. PubMed ID: 1851408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].
    Ota K; Ohno R; Shirakawa S; Masaoka T; Okada K; Ohashi Y; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1047-55. PubMed ID: 8210256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
    de Forni M; Bugat R; Chabot GG; Culine S; Extra JM; Gouyette A; Madelaine I; Marty ME; Mathieu-Boué A
    Cancer Res; 1994 Aug; 54(16):4347-54. PubMed ID: 8044782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irinotecan hydrochloride (CPT-11)].
    Furue H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.